查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800144

全球宠物疫苗市场：2025 年至 2030 年预测

Global Pet Vaccine Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计宠物疫苗市场规模到2025年将达到14,260亿美元，到2030年将达到19,250亿美元，复合年增长率为6.19%。

受宠物拥有率上升、宠物健康意识增强以及通用感染疾病日益流行的推动，宠物疫苗市场可望稳定成长。宠物疫苗对于维持动物免疫力和保护社区健康（尤其是预防狂犬病等疾病）至关重要。技术进步、政府扶持措施以及不断增加的研发投入正在进一步推动市场扩张。犬用疫苗市场，尤其是注射疫苗，由于其在预防感染疾病的有效性，预计将实现显着增长。

市场成长动力

宠物拥有量的增加和疾病的传播

宠物拥有量的激增，尤其是在千禧世代中，推动了宠物疫苗的需求，因为饲主更加重视宠物的健康。狂犬病等通用感染疾病的爆发凸显了定期接种疫苗的必要性。狂犬病主要由犬类传播，仍是全球主要的健康隐患，在东南亚等地区发病率较高。疫苗在预防此类疾病方面的有效性，加上公众意识的不断提高和动物福利宣传活动的发展，正在推动市场成长。

技术进步和政府支持

疫苗研发的技术创新正在提高疫苗的有效性和安全性，并支持其市场推广。政府采取的积极倡议，包括补贴和意识提升活动，正在鼓励宠物疫苗接种，尤其是在疾病负担较高的地区。不断增加的研发支出正在支持先进疫苗的引进，以应对新出现的健康挑战并扩大市场潜力。人们对皮下或肌肉注射疫苗的日益关注，凸显了疫苗在刺激强大免疫反应方面的作用，并已成为兽医学的基石。

犬用疫苗市场的扩张

预计犬用疫苗产业将迎来显着成长，这主要得益于对抗狂犬病、犬小病毒和钩端螺旋体病等常见疾病的需求。注射疫苗旨在预防传染性病原体，因其可靠且易于兽医专业人员使用而广泛应用。全球对狂犬病疫苗的需求，尤其是在中低收入国家，进一步推动了该产业的发展，联合国儿童基金会等组织也确保了疫苗的可负担供应。

地理视角

美国凭藉其庞大的宠物数量和高宠物拥有率（尤其是在千禧世代家庭中）在北美宠物疫苗市场占据主导地位。美国对宠物健康的重视，加上自身对人类健康改善等益处，支撑了疫苗的需求。庞大的犬猫种群使得定期接种疫苗成为必需，从而催生了强劲的市场。加拿大等其他北美国家也透过不断增长的宠物拥有量和宠物意识做出了贡献。预计亚太地区将迎来快速成长，这得益于印度和中国等国宠物拥有量的成长以及政府推出的健康倡议。

宠物疫苗市场预计将稳定成长，这得益于宠物主人数量的增加、通用感染疾病的流行以及疫苗技术的进步。犬用疫苗，尤其是注射疫苗，因其在疾病预防中的重要角色而引领市场。虽然美国仍然是领先的市场，但亚太地区显示出强劲的成长潜力。政府的支持和研发投入进一步提升了市场前景。宠物健康意识的增强将推动对有效疫苗的需求，从而推动市场持续扩张。

本报告的主要优点

  • 深入分析：深入了解主要和新兴地区的市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力进行策略决策并在动态环境中开闢新的业务流和收益。
  • 适合广泛的使用者：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具有成本效益的。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2020 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是趋势）、财务资讯和关键发展

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

5. 全球宠物疫苗市场（依动物类型）

  • 介绍
  • 狗
  • 猫
  • 马
  • 鸟类
  • 其他的

6. 全球宠物疫苗市场（依疫苗接种类型）

  • 介绍
  • 核心疫苗
  • 非核心疫苗
  • 其他的

7. 全球宠物疫苗市场（依接种方式）

  • 介绍
  • 注射疫苗
  • 鼻内疫苗
  • 口服疫苗

8. 全球宠物疫苗市场（依分销管道）

  • 介绍
  • 兽医诊所
  • 零售药局
  • 线上平台
  • 兽医诊所

9. 全球宠物疫苗市场（按地区）

  • 介绍
  • 北美洲
    • 依动物类型
    • 透过接种疫苗
    • 按接种方式
    • 按分销管道
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依动物类型
    • 透过接种疫苗
    • 按接种方式
    • 按分销管道
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依动物类型
    • 透过接种疫苗
    • 按接种方式
    • 按分销管道
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依动物类型
    • 透过接种疫苗
    • 按接种方式
    • 按分销管道
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依动物类型
    • 透过接种疫苗
    • 按接种方式
    • 按分销管道
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第十章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章：公司简介

  • Zoetis
  • Merck Animal Health（MSD）
  • Elanco
  • Boehringer Ingelheim
  • Virbac
  • Vetoquinol
  • Ceva Sante Animale
  • Tianjin Ringpu Bio-Technology

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611148

The Global Pet Vaccine Market is expected to USD 1,426 billion in 2025 to USD 1,925 billion in 2030, at a CAGR of 6.19%.

The global pet vaccine market is poised for steady growth, driven by rising pet ownership, increasing awareness of pet health, and the growing prevalence of zoonotic diseases. Pet vaccines are essential for maintaining animal immunity and safeguarding community health, particularly against diseases like rabies. Technological advancements, supportive government initiatives, and increased R&D investments further propel market expansion. The canine vaccine segment, especially injectable vaccines, is expected to see substantial growth due to their effectiveness in preventing infectious diseases.

Market Growth Drivers

Rising Pet Ownership and Disease Prevalence

The surge in pet ownership, particularly among millennials, drives demand for pet vaccines as owners prioritize animal health. The increasing prevalence of zoonotic diseases, such as rabies, underscores the need for regular vaccinations. Rabies, transmitted primarily by dogs, remains a significant global health concern, with high incidence in regions like Southeast Asia. The effectiveness of vaccines in preventing such diseases, coupled with growing public awareness and animal welfare campaigns, fuels market growth.

Technological Advancements and Government Support

Innovations in vaccine development enhance efficacy and safety, boosting market adoption. Positive government initiatives, including subsidies and awareness programs, encourage pet vaccinations, particularly in regions with high disease burdens. Rising R&D expenditure supports the introduction of advanced vaccines, addressing emerging health challenges and expanding market potential. The focus on injectable vaccines, administered subcutaneously or intramuscularly, highlights their role in stimulating robust immune responses, making them a cornerstone of veterinary medicine.

Canine Vaccine Market Expansion

The canine vaccine segment is anticipated to grow significantly, driven by the need to combat common diseases like rabies, canine parvovirus, and leptospirosis. Injectable vaccines, designed to protect against infectious pathogens, are widely used due to their reliability and ease of administration by veterinary professionals. The global demand for rabies vaccines, particularly in low- and middle-income countries, further bolsters this segment, supported by organizations like UNICEF ensuring affordable supply.

Geographical Outlook

The United States dominates the North American pet vaccine market, driven by a large pet population and high pet ownership rates, particularly among millennial households. The country's focus on pet health, linked to benefits like improved human well-being, supports demand for vaccines. The substantial dog and cat population requires regular vaccinations, creating a robust market. Other North American countries, like Canada, also contribute through growing pet adoption and awareness. The Asia-Pacific region is expected to witness rapid growth, fueled by increasing pet ownership and government-backed health initiatives in countries like India and China.

The pet vaccine market is set for steady growth, propelled by rising pet ownership, zoonotic disease prevalence, and advancements in vaccine technology. The canine segment, particularly injectable vaccines, leads due to its critical role in disease prevention. The United States remains a key market, while Asia-Pacific shows strong growth potential. Government support and R&D investments further enhance market prospects. As pet health awareness grows, the demand for effective vaccines is expected to rise, ensuring sustained market expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Pet Vaccine Market Segmentation:

By Animal Type

  • Canine
  • Feline
  • Equine
  • Avian
  • Others

By Vaccination

  • Core Vaccines
  • Non-Core Vaccines
  • Others

By Administration

  • Injectable Vaccines
  • Intranasal Vaccines
  • Oral Vaccines

By Distribution Channel

  • Veterinary Clinics
  • Retail Pharmacies
  • Online Platforms
  • Animal Hospitals

By Geography

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PET VACCINE MARKET BY ANIMAL TYPE

  • 5.1. Introduction
  • 5.2. Canine
  • 5.3. Feline
  • 5.4. Equine
  • 5.5. Avian
  • 5.6. Others

6. GLOBAL PET VACCINE MARKET BY VACCINATION

  • 6.1. Introduction
  • 6.2. Core Vaccines
  • 6.3. Non-Core Vaccines
  • 6.4. Others

7. GLOBAL PET VACCINE MARKET BY ADMINISTRATION

  • 7.1. Introduction
  • 7.2. Injectable Vaccines
  • 7.3. Intranasal Vaccines
  • 7.4. Oral Vaccines

8. GLOBAL PET VACCINE MARKET BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Veterinary Clinics
  • 8.3. Retail Pharmacies
  • 8.4. Online Platforms
  • 8.5. Animal Hospitals

9. GLOBAL PET VACCINE MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Animal Type
    • 9.2.2. By Vaccination
    • 9.2.3. By Administration
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Animal Type
    • 9.3.2. By Vaccination
    • 9.3.3. By Administration
    • 9.3.4. By Distribution Channel
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Animal Type
    • 9.4.2. By Vaccination
    • 9.4.3. By Administration
    • 9.4.4. By Distribution Channel
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Animal Type
    • 9.5.2. By Vaccination
    • 9.5.3. By Administration
    • 9.5.4. By Distribution Channel
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Animal Type
    • 9.6.2. By Vaccination
    • 9.6.3. By Administration
    • 9.6.4. By Distribution Channel
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Zoetis
  • 11.2. Merck Animal Health (MSD)
  • 11.3. Elanco
  • 11.4. Boehringer Ingelheim
  • 11.5. Virbac
  • 11.6. Vetoquinol
  • 11.7. Ceva Sante Animale
  • 11.8. Tianjin Ringpu Bio-Technology

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations